At a glance
- Originator SmithKline Beecham Biologicals
- Developer NiKem Research; SmithKline Beecham Biologicals
- Class Indoles; Osteoporosis therapies; Piperidines
- Mechanism of Action Bone resorption factor inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Postmenopausal osteoporosis